VERAFILM™
Complex wound healing (e.g., Diabetic Foot Ulcers)
Key Facts
About CollPlant Biotechnologies
CollPlant Biotechnologies' mission is to leverage its unique, plant-derived recombinant human collagen (rhCollagen) as a foundational biomaterial to advance regenerative and aesthetic medicine. The company's key achievement is the establishment of a scalable GMP manufacturing platform using genetically engineered tobacco plants, producing Type I and Type III human collagen with high purity and consistency. Its strategy focuses on developing an internal product pipeline in aesthetics and wound care while actively partnering its rhCollagen and bio-inks with leading firms in the 3D bioprinting and medical device sectors. Despite being a micro-cap company facing clinical and financial challenges, its technology represents a significant long-term opportunity in the shift towards sustainable, non-animal biomaterials.
View full company profile